Dendritic Cell-Based Cancer Immunotherapy against Multiple Myeloma: From Bench to Clinic / 전남의대학술지
Chonnam Medical Journal
; : 1-7, 2015.
Article
em En
| WPRIM
| ID: wpr-788307
Biblioteca responsável:
WPRO
ABSTRACT
Although the introduction of stem cell transplantation and novel agents has improved survival, multiple myeloma (MM) is still difficult to cure. Alternative approaches are clearly needed to prolong the survival of patients with MM. Dendritic cell (DC) therapy is a very promising tool immunologically in MM. We developed a method to generate potent DCs with increased Th1 polarization and migration ability for inducing strong myeloma-specific cytotoxic T lymphocytes. In this review, we discuss how the efficacy of cancer immunotherapy using DCs can be improved in MM.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Células Dendríticas
/
Linfócitos T Citotóxicos
/
Transplante de Células-Tronco
/
Imunoterapia
/
Mieloma Múltiplo
Limite:
Humans
Idioma:
En
Revista:
Chonnam Medical Journal
Ano de publicação:
2015
Tipo de documento:
Article